GE HealthCare Technologies (GEHC) Price to Sales (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported Price to Sales for 5 consecutive years, with 5.46 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 19.15% year-over-year to 5.46; the trailing twelve-month figure through Jun 2026 stood at 1.36 (down 19.73% YoY), and the FY2025 full-year result was 1.81, changed 0.27% from the prior year.
• Price to Sales slipped to 5.46 in Q2 2026 per GEHC's latest filing, from 6.31 in the prior quarter.
• Across five years, Price to Sales topped out at 8.92 in Q1 2024 and bottomed at 5.37 in Q4 2022.
• Historically, Price to Sales has averaged 7.03 across 5 years, with a median of 6.75 in 2025.
• The sharpest annual moves came in 2024 and 2025: Price to Sales jumped 37.27% in 2024, then retreated 24.56% in 2025.
• Over 5 years, Price to Sales stood at 5.37 in 2022, then climbed by 26.02% to 6.76 in 2023, then decreased by 0.61% to 6.72 in 2024, then fell by 2.4% to 6.56 in 2025, then fell by 16.77% to 5.46 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 5.46, 6.31, and 6.56 for Q2 2026, Q1 2026, and Q4 2025 respectively.